Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the appointment of James (Jamie) Levine as chief financial officer.
“I am confident that Jamie’s diverse background in finance and experience on Wall Street, as well as Jessica’s breadth of legal experience in clinical development through to commercialization, will be tremendous assets to our company.” - Jeffrey Stein, Ph.D., president and chief executive officer of Cidara
unknownx500
More posts by Erik Lundh
Recent posts from Park Square Executive Search
